Showing results (1851-1860 of 5,801) with videos related to

Sort By:
Pageof 581
Work (Reading, Mass.)|November 13, 2020
School quality of life: Cross-national comparison of students' perspectivesAsnat Bar-Haim Erez, Stefan Kuhle, Jessie-Lee McIsaac, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2020
Identification of nephronectin as a new target for IGF1 actionRive Sarfstein, Lena Lapkina-Gendler, Karthik Nagaraj, et al.
Nanotechnology|October 15, 2020
Ultrasound-induced and MRI-monitored CuO nanoparticles release from micelle encapsulationRoana N Schiopu Aresteanu, Alexander Borodetsky, Haim Azhari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 6, 2019
Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH)Moran Haim Zada, Michael Kubek, Wahid Khan, et al.
Journal of Gynecology Obstetrics and Human Reproduction|May 13, 2021
Maternal and fetal outcomes of urolithiasis: A retrospective cohort studyNatasha Sebastian, Nicholas Czuzoj-Shulman, Andrea R Spence, et al.
Clinical Oral Investigations|May 17, 2020
Peri-implant disease affects systemic complete blood count values-an experimental in vivo studyLiat Chaushu, Haim Tal, Anton Sculean, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 25, 2021
Characteristics and outcomes among pregnant women with end-stage renal disease on hemodialysisAnat Lavie, Nicholas Czuzoj-Shulman, Andrea R Spence, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 10, 2021
Clinical presentation and management of urolithiasis in the obstetric patient: a matched cohort studyNatasha Sebastian, Nicholas Czuzoj-Shulman, Andrea R Spence, et al.
The Prostate|September 26, 2006
The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancerAvi Orr-Urtreger, Anat Bar-Shira, Haim Matzkin, et al.
European Journal of Gastroenterology & Hepatology|June 30, 2021
Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experienceVered Richter, Anton Bermont, Daniel L Cohen, et al.
Pageof 581